Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.9%

126 terminated/withdrawn out of 1059 trials

Success Rate

82.5%

-4.0% vs industry average

Late-Stage Pipeline

10%

111 trials in Phase 3/4

Results Transparency

48%

285 of 595 completed trials have results

Key Signals

145 recruiting285 with results79 terminated47 withdrawn

Enrollment Performance

Analytics

N/A

449(55.5%)

Phase 2

127(15.7%)

Phase 1

91(11.2%)

Phase 4

90(11.1%)

Early Phase 1

31(3.8%)

Phase 3

21(2.6%)

809Total

N/A(449)

Phase 2(127)

Phase 1(91)

Phase 4(90)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1059)

Showing 20 of 1059 trials

NCT04104139Phase 1Active Not Recruiting

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

Role: collaborator

NCT06504459Phase 2Recruiting

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Role: collaborator

NCT05758493Phase 2Recruiting

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Role: lead

NCT06171724Early Phase 1Terminated

Ashwagandha Pharmacokinetics Study in Older Adults

Role: lead

NCT06970392Not ApplicableRecruiting

Brief Sleep Intervention for Bedtime Resistance

Role: lead

NCT07520331Not ApplicableNot Yet Recruiting

Using the Adaptive Behavioral Counseling Decision Framework to Guide Single-Session Intervention for Preschool Behavioral Concerns in Pediatric Primary Care: A Feasibility Trial

Role: lead

NCT06124716Not ApplicableActive Not Recruiting

Collaboration Oriented Approach to Controlling High Blood Pressure

Role: lead

NCT07326722Not ApplicableRecruiting

Delivering tAN to Reduce HMB: The LUNA Study

Role: collaborator

NCT03361436Phase 1Active Not Recruiting

Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

Role: collaborator

NCT03699995Not ApplicableTerminated

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

Role: collaborator

NCT04993313Not ApplicableActive Not Recruiting

Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study

Role: collaborator

NCT07504835Not ApplicableNot Yet Recruiting

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

Role: collaborator

NCT06342453Not ApplicableRecruiting

CREATE: Art for Children With Cancer

Role: collaborator

NCT07498517Phase 2Not Yet Recruiting

Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT

Role: collaborator

NCT04260256Phase 2Terminated

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Role: collaborator

NCT03874052Phase 1Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT07089940Early Phase 1Recruiting

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT04627662Not ApplicableCompleted

Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA

Role: lead

NCT07385430Phase 1Not Yet Recruiting

Study of LGW16-03 To Identify Nerves

Role: collaborator

NCT06335966Active Not Recruiting

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

Role: collaborator